These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17913865)

  • 1. Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody.
    Welsch JA; Granoff D
    Clin Vaccine Immunol; 2007 Dec; 14(12):1596-602. PubMed ID: 17913865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of phenotypically indistinguishable but geographically distinct Neisseria meningitidis Group B isolates in a serum bactericidal antibody assay.
    Findlow J; Holland A; Andrews N; Weynants V; Sotolongo F; Balmer P; Poolman J; Borrow R
    Clin Vaccine Immunol; 2007 Nov; 14(11):1451-7. PubMed ID: 17881507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequacy of colominic acid as an absorbent intended to facilitate use of complement-preserved baby rabbit serum in the Neisseria meningitidis serogroup B serum bactericidal antibody assay.
    Findlow J; Holland A; Martin D; Oster P; Balmer P; Borrow R
    Clin Vaccine Immunol; 2007 May; 14(5):556-61. PubMed ID: 17344344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.
    Plested JS; Welsch JA; Granoff DM
    Clin Vaccine Immunol; 2009 Jun; 16(6):785-91. PubMed ID: 19339487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.
    Partridge E; Lujan E; Giuntini S; Vu DM; Granoff DM
    Vaccine; 2017 Jul; 35(33):4236-4244. PubMed ID: 28651840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine.
    Lujan E; Partridge E; Giuntini S; Ram S; Granoff DM
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.
    Vu DM; Wong TT; Granoff DM
    Vaccine; 2011 Feb; 29(10):1968-73. PubMed ID: 21241734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.
    Jordens JZ; Williams JN; Jones GR; Christodoulides M; Heckels JE
    Infect Immun; 2004 Nov; 72(11):6503-10. PubMed ID: 15501781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.
    Frosi G; Biolchi A; Lo Sapio M; Rigat F; Gilchrist S; Lucidarme J; Findlow J; Borrow R; Pizza M; Giuliani MM; Medini D
    Vaccine; 2013 Oct; 31(43):4968-74. PubMed ID: 23954380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 12. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.
    Maslanka SE; Gheesling LL; Libutti DE; Donaldson KB; Harakeh HS; Dykes JK; Arhin FF; Devi SJ; Frasch CE; Huang JC; Kriz-Kuzemenska P; Lemmon RD; Lorange M; Peeters CC; Quataert S; Tai JY; Carlone GM
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):156-67. PubMed ID: 9067649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
    Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
    Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the bactericidal antibody against Neisseria meningitidis serogroup C strains after immunization with a divalent polysaccharide (A plus C) vaccine].
    Xu L; Luo LZ; Zhu BQ; He L; Gao Y; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):619-21. PubMed ID: 19957632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci.
    Giuntini S; Lujan E; Gibani MM; Dold C; Rollier CS; Pollard AJ; Granoff DM
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus.
    Lujan E; Winter K; Rovaris J; Liu Q; Granoff DM
    Clin Infect Dis; 2017 Oct; 65(7):1112-1119. PubMed ID: 28582542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine.
    Harris SL; King WJ; Ferris W; Granoff DM
    Infect Immun; 2003 Jan; 71(1):275-86. PubMed ID: 12496177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison on the levels of human serum antibody against Neisseria meningitidis serogroup C measured using serum bactericidal assay and ELISA].
    Zhu BQ; Xu L; Zhou HJ; Shao ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):521-4. PubMed ID: 22883183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Michaelsen TE; Aase A; Käyhty H
    Infect Immun; 2005 Aug; 73(8):4694-703. PubMed ID: 16040982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci.
    Harris SL; Tan C; Andrew L; Hao L; Liberator PA; Absalon J; Anderson AS; Jones TR
    Vaccine; 2018 Oct; 36(45):6867-6874. PubMed ID: 30269916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.